Pre-filled Syringes Conference 2021 to Address Key Innovations in Injectable Drug Delivery
Key Insights
SMi Group's 13th annual Pre-filled Syringes Conference will convene industry leaders in London to discuss advances in biologics delivery, device design, and EU MDR implementation.
The two-day conference will feature expert presentations on novel drug products, parenteral packaging innovations, and lifecycle management strategies for combination products.
Early registration offers a £400 discount until September 30, 2020, with additional pre-conference workshops focusing on digital health and long-acting injectable developments.
The injectable drug delivery landscape is poised for significant advancement as the Pre-filled Syringes and Injectable Drug Devices Conference prepares for its 13th annual gathering in London on January 13-14, 2021. The event comes at a crucial time when the industry is experiencing unprecedented growth driven by increasing demand for self-administration devices and biologics delivery systems.
Key Industry Trends and Regulatory Focus
The conference agenda addresses critical developments in the pre-filled syringes (PFS) sector, with particular emphasis on the European Medical Device Regulation (EU MDR) and Article 117 implementation. Industry experts will explore the latest innovations in biologics delivery, large-volume administration systems, and combination product development.
Technical Innovation and Device Design
Sessions will delve into cutting-edge developments in parenteral packaging and device platforms for combination products. Attendees will gain insights into novel design approaches and engineering solutions that address the growing complexity of injectable drug delivery systems.
Networking and Professional Development
The event offers unique networking opportunities with an impressive roster of industry professionals, including:
- Global Product Managers
- Senior Pre-Filled Syringes Engineers
- Device Testing Managers
- Heads of Late-Stage PFS Development
- Senior Directors of Combination Products
- Regulatory Affairs Specialists
Pre-Conference Workshops
Two specialized workshops will precede the main conference on January 12:
The first workshop, led by Andrew Dundon of PharMechceutics Ltd, will examine digital health opportunities and adoption challenges in the injectable device space. A second workshop, conducted by Joël Richard, Chief Development Officer at MedinCell (search), will focus on the development challenges and drivers for long-acting injectable formulations.
Industry Support and Sponsorship
Leading medical device companies including BD Medical (search), Harro Hoefliger (search), Nemera (search), Owen Mumford (search), and Zeon (search) have announced their sponsorship of the event, highlighting the industry-wide recognition of the conference's significance.
Registration and Attendance Details
Early registrants can benefit from a £400 discount for bookings made before September 30, 2020. The conference promises to deliver valuable insights through case studies, regulatory updates, and real-world examples of successful device development and commercialization strategies.